Boning Up on Irisin
Abstract
This article explores the role of irisin, a myokine derived from the protein FNDC5, in mediating the metabolic benefits of exercise, particularly its effects on bone and fat tissue. Irisin is secreted by skeletal muscle during physical activity and has been implicated in bone remodeling and adipose tissue browning. Recent research by Kim et al. demonstrates that irisin binds to αV integrin receptors on osteocytes, reducing sclerostin production and potentially mitigating bone loss. However, this mechanism may also mimic the effects of mechanical unloading, raising questions about its role in exercise induced bone protection. Additionally, irisin promotes thermogenesis in white adipose tissue via integrin signaling, suggesting therapeutic potential for obesity related disorders. The article highlights the dual implications of irisin as both a potential treatment target for osteoporosis and a cautionary note for its use in metabolic therapies due to possible side effects.